Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 223.43M P/E - EPS this Y 4.20% Ern Qtrly Grth -
Income -57.59M Forward P/E -40.63 EPS next Y 89.90% 50D Avg Chg -3.00%
Sales 25.54M PEG - EPS past 5Y - 200D Avg Chg -6.00%
Dividend N/A Price/Book 4.36 EPS next 5Y - 52W High Chg -64.00%
Recommedations 1.20 Quick Ratio 4.63 Shares Outstanding 34.37M 52W Low Chg 31.00%
Insider Own 0.17% ROA -38.50% Shares Float 28.31M Beta 1.10
Inst Own 44.73% ROE -125.94% Shares Shorted/Prior 1.57M/1.89M Price 6.50
Gross Margin -7.52% Profit Margin -225.54% Avg. Volume 275,795 Target Price 19.75
Oper. Margin -219.66% Earnings Date Nov 8 Volume 102,239 Change -0.46%
AVEO Pharmaceuticals, Inc. News
11/12/21 Despite Lacking Profits AVEO Pharmaceuticals (NASDAQ:AVEO) Seems To Be On Top Of Its Debt
11/10/21 AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences
11/08/21 AVEO Pharmaceuticals (AVEO) Reports Q3 Loss, Tops Revenue Estimates
11/08/21 AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
11/01/21 Analysts Estimate AVEO Pharmaceuticals (AVEO) to Report a Decline in Earnings: What to Look Out for
11/01/21 AVEO Oncology to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021
09/20/21 AVEO Oncology Announces Ficlatuzumab Granted Fast Track Designation by the U.S. FDA for the Treatment of Relapsed or Recurrent Head and Neck Squamous Cell Carcinoma
09/13/21 Great news for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO): Insiders acquired stock in large numbers last year
08/05/21 AVEO Pharmaceuticals (AVEO) Reports Q2 Loss, Misses Revenue Estimates
08/05/21 AVEO Oncology Reports Second Quarter 2021 Financial Results and Provides Business Update
07/29/21 AVEO Oncology to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021
07/08/21 AVEO Oncology to Host Key Opinion Leader Webinar on FOTIVDA® (tivozanib) for Relapsed or Refractory Renal Cell Carcinoma
06/07/21 AVEO Oncology to Host Key Opinion Leader Webinar on Ficlatuzumab in Head and Neck Squamous Cell Carcinoma
05/25/21 AVEO Oncology to Present at the Jefferies 2021 Virtual Healthcare Conference
05/19/21 AVEO Oncology Announces Presentation of Long-Term Efficacy Follow Up, Additional Tolerability Data from the Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Relapsed or Refractory Renal Cell Carcinoma
05/19/21 AVEO Oncology Announces Positive Results from Randomized Phase 2 Study of Ficlatuzumab in Combination with Cetuximab in Pan-Refractory, Metastatic HNSCC
05/10/21 AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Tops Revenue Estimates
05/10/21 AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update
05/10/21 AVEO Pharmaceuticals, Inc. to Host Earnings Call

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC. The company has also completed a Phase II clinical trial of tivozanib in combination with Opdivo (nivolumab) for the treatment of RCC. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of squamous cell carcinoma of the head and neck, pancreatic cancer, and acute myeloid leukemia; AV-203, a potent humanized IgG1 monoclonal antibody, which completed Phase I clinical trial for treating human ErbB3; and AV-380, a potent humanized IgG1 inhibitory monoclonal antibody that is in a Phase I clinical trial for the treatment or prevention of cachexia. The company's preclinical stage product includes AV-353 that targets the Notch 3 pathway. AVEO Pharmaceuticals, Inc. has collaboration agreements with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec International GmbH; Kyowa Kirin Co., Ltd.; AstraZeneca PLC; and Bristol Myers Squibb. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.

AVEO Chatroom

User Image ReturnoftheMax Posted - 13 hours ago

$ISPC Hello beautiful. I've been waiting for u... This is just today's short volume. U realize this is what happened at $LGVN right! U realize our trade float is only 2.1mil right? $KTTA $AVEO

User Image Conan2315 Posted - 21 hours ago

$AVEO

User Image AlexSmith228 Posted - 23 hours ago

$AVEO

User Image ReturnoftheMax Posted - 23 hours ago

$BFRI no shares left and ridiculous borrow if the can find. Tiny float hasn't run yet analyst 20pt. Why aren't u buying....$ISPC $$AVEO

User Image AlexSmith228 Posted - 1 day ago

$AVEO good time to......SELL THIS POS 🤣

User Image Oilglutton Posted - 1 day ago

$AVEO Aveo owners: soup kitchen lineup starts soon. Best to get there early... Lots of leftover turkey including AVEO!!! Hahahaha... Leave this garbage by the .

User Image Theodore81 Posted - 1 day ago

$AVEO holding up well today but it’s been tough to watch last week or 2. Still believe the payoff will be big, and soon

User Image nicklaus2 Posted - 1 day ago

$AVEO new short interest numbers are out for Nov 15th. Short interest is down about 250k shares. My interpretation of that is the shorts knows this is a winner and they are slowly trying to take in their short w/o moving the stock up too much. We should get some dips in the stock from time to time and those dips should be bought imo. https://www.nasdaq.com/market-activity/stocks/aveo/short-interest

User Image bluetraiding92 Posted - 1 day ago

$AVEO waiting for buy signal on AVEO

User Image T8skmod Posted - 1 day ago

$AVEO Twits Stats Today's Change 23% + 🚀 https://t8sk.com/AVEO

User Image bluetraiding92 Posted - 1 day ago

$AVEO Awaiting BUY signal on AVEO with ultraalgo.com/?affiliate_id=GhostTrader12

User Image ChartMill Posted - 2 days ago

$AVEO: When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we s ... https://www.chartmill.com/stock/analyzer/stock/AVEO?view=fundamental-analysis&key=815aad62-a77c-4902-a7d1-78cc54d456bc&utm_source=stocktwits&utm_medium=FA&utm_content=AVEO&utm_campaign=social_tracking

User Image 75guyjax Posted - 2 days ago

$OCGN $ZOM $AVEO bio unity holding strong! This is what is coming on December 7-10 for $JAGX look at the target audience 👀 doctors are the ones who will order this game-changing medicine! First in the U.S and then around the world!! This is just one reason why jagx is a very strong buy! Analysts rate this a strong buy with a PT of 15.00.

User Image Conan2315 Posted - 2 days ago

$AVEO what happened bears on holiday today

User Image delalove Posted - 3 days ago

$AVEO wtf? This pos is so poorly managed right now.

User Image Oilglutton Posted - 3 days ago

$AVEO Down again today! No surprise there. $4 on Dec 31, 2021. Hahaha.

User Image Tickstocks Posted - 3 days ago

$AVEO Twits Stats Today's Change 23% + 🚀 https://t8sk.com/AVEO

User Image AlexSmith228 Posted - 3 days ago

$AVEO

User Image MidwestApe Posted - 3 days ago

$AVEO lol seriously, wtf?

User Image tickeron Posted - 3 days ago

Does this make you nervous? $AVEO price exceeded its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/3181614

User Image OldManLogan Posted - 3 days ago

$AVEO $AUPH https://www.bloomberg.com/news/articles/2021-11-16/bristol-myers-launching-new-drugs-after-bulking-up-pipeline This is most relevant to the AUPH board, obviously, given that nice lady specifically calls out Aurinia (BTW, CEO's response absolutely confirms that they are in fact in talks with AUPH) but AVEO shareholders should listen to his comments about small and midsized buyouts as well... BMY clearly comfortable with smaller bolt on acquisitions and they prefer to establish partnerships first.. i.e TINIVO for the win.

User Image AlexSmith228 Posted - 4 days ago

$AVEO sell this POS

User Image kareen Posted - 4 days ago

$PTPI $AVEO

User Image Oilglutton Posted - 4 days ago

$AVEO save your portfolio: sell 1/2 of your Aveo shares and by Dec 31, 2021 you will have 1/2 of your money... The other half will be cheap toilet paper! Hahahahaha

User Image papasmurf6969 Posted - 4 days ago

$AVEO https://www.youtube.com/watch?v=u5k_arVcqR8

User Image Chiel0706 Posted - 4 days ago

$AVEO

User Image bluetraiding92 Posted - 4 days ago

$AVEO Waiting for buy signal on AVEO

User Image LiquidSignals Posted - 4 days ago

LiquidTheta® Trade Alert (Delayed/Actionable) Ticker: $AVEO Buy: Apr 14 2022 $7.00 Calls Entry Price: $1.00- $1.55 TP1: $1.20 TP2: $1.35 TP3: $1.50 Stop Loss: $0.86 (Optional) Highly Profitable Options Signals Delivered to Your Inbox

User Image SpencerF Posted - 4 days ago

$AVEO $SEEL $HEPA if this market could make up its mind on if we’re doing the make money thing or the Great Depression thing, that would be great.

User Image AlexSmith228 Posted - 4 days ago

$AVEO the trend is back ☝️😜

Analyst Ratings
HC Wainwright & Co. Buy Jul 12, 21
SVB Leerink Outperform Mar 11, 21
SVB Leerink Outperform Jan 19, 21
SVB Leerink Outperform Nov 25, 20
HC Wainwright & Co. Buy Nov 25, 20
Piper Sandler Overweight Nov 25, 20
H.C. Wainwright Buy Nov 25, 20
HC Wainwright & Co. Buy Nov 25, 20
H.C. Wainwright Buy Nov 25, 20